Graves' Ophthalmopathy: A 1987 Update

References

• Riddick FA: Immunologic aspects of thyroid disease. Ophthalmol 1981; 88:471–475.
   Web of Science ®Google Scholar
• Rabinowe AU, Eisenbarth GS: Polyglandular autoimmunity. Adv Intern Med 1986; 31: 293–307.
   PubMedGoogle Scholar
• Faryna M, Nauman J, Gardas A: Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy. Br Med J 1985; 290:191–192.
   PubMed Web of Science ®Google Scholar
• Kendall AV, Taylor P, Atkinson S, et al: A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J 1984; 288:1183–1186.
   Google Scholar
• Konishi J, Herman MM, Kriss JP: Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extra-ocular muscle membrane. Endocrinol 1974; 95(2):434–446.
   Web of Science ®Google Scholar
• Mullin BR, Levinson RE, Friedman A, et al: Delayed hypersensitivity in Graves' disease and exophthalmos: Identification of thyroglobulin in normal human orbital muscle. Endocrinol 1977; 100(2):351–366.
   Web of Science ®Google Scholar
• Kodama AU, Sikorska H, Bayly R, et al: Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy. J Clin Endocrinol Metab 1984; 59(1):67–73.
   Web of Science ®Google Scholar
• Blau HM, Kaplan I, Tao T, et al: Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci 1983; 32:45–53.
   PubMed Web of Science ®Google Scholar
• Felberg NT, Sergott RC, Savino PJ, et al: Lymphocyte subpopulations in Graves' ophthalmopathy. Arch Ophthalmol 1985; 103: 656–659.
   PubMedGoogle Scholar
• Weetman AP, McGregor AM, Ludgate M, et al: Cyclosporine A improves Graves' ophthalmopathy. Lancet 1983; 2:486–489.
   PubMed Web of Science ®Google Scholar
• Sergott RC: Graves' ophthalmopathy: A clinical immunologic update. Ophthalmol Annual 1986; 2:343–355.
   Google Scholar
• Werner SC, Coleman DJ, Franzen LA: Ultrasonographic evidence of a consistent orbital involvement in Graves' disease. N Engl J Med 1974; 290:1447–1450.
   PubMed Web of Science ®Google Scholar
• Enzmann DR, Donaldson SS, Kriss JP: Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr 1979; 3:815–819.
   PubMed Web of Science ®Google Scholar
• Gamblin AV, Harper DG, Galentine P, et al: Prevalence of increased intraocular pressures in Graves' disease—evidence of frequent subclinical ophthalmopathy. N Engl J Med 1983; 308:420–424.
   PubMed Web of Science ®Google Scholar
• Swillens S, Ludgate M, Mercken L, et al: Analysis of sequence and structure homologies between thyroglobulin and acetylcholinestherase: Possible functional and clinical significance. Biochem Biophys Res Commun 1986; 137:142–148.
   PubMed Web of Science ®Google Scholar
• Trokel SL, Jakobiec FA: Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmol 1981; 88: 553–564.
   PubMed Web of Science ®Google Scholar
• Wagener HP: Lesons of the optic nerve and exophthalmos of endocrine origin. Am J Med Sci 1956; 232:226–239.
   Web of Science ®Google Scholar
• Feldon SE, Muramatsu S, Werner JM: Clinical classification of Graves' ophthalmopathy. Identification of risk factors for optic neuropathy. Arch Ophthalmol 1984; 102:1469–1472.
   PubMedGoogle Scholar
• Trobe JD, Glaser JS, Laflamme P: Dysthyroid optic neuropathy: Clinical profile and rationale for management. Arch Ophthalmol 1978; 96: 1199–1209.
   PubMedGoogle Scholar
• Feldon SE, Lee CP, Muramatsu SK, Werner JM: Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy. Arch Ophthalmol 1985; 103:213–215.
   PubMedGoogle Scholar
• Gay AJ, Wolkstein MA: Topical guanethidine therapy for endocrine lid retraction. Arch Ophthalmol 1966; 76:364–367.
   PubMedGoogle Scholar
• Grove AS Jr: Upper eyelid retraction and Graves' disease. Ophthalmol 1981; 88:499–506.
   PubMed Web of Science ®Google Scholar
• Char DH: Thyroid Eye Disease. Baltimore: Williams and Wilkins, 1985.
   Google Scholar
• Gorman CA: Temporal Relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 1983; 58:515–519.
   PubMed Web of Science ®Google Scholar
• Werner SE, Feind CR, Aida M: Graves' disease and total thyroidectomy. N Engl J Med 1967; 276:132–138.
   PubMedGoogle Scholar
• Weetman AP, McGregor AM, Hall R: Ocular manifestations of Graves' disease: A review. J Royal Soc Med 1984; 77:936–942.
   Web of Science ®Google Scholar
• Kinyoun JL, Kaline RE, Brower SA, et al: Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Arch Ophthalmol 1984; 102:1473–1476.
   PubMedGoogle Scholar
• Bartalena L, Marcocci C, Chiovato L, et al: Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: A comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983; 56:1139–1144.
   PubMed Web of Science ®Google Scholar
• Shorr N, Neuhaus R, Baylis HI: Ocular motility problems after orbital decompression for dysthyroid ophthalmopathy. Ophthalmol 1982; 89:323–328.
   PubMed Web of Science ®Google Scholar
• Burrow GN, Mitchell MS, Howard RO, et al: Immunosuppressive therapy for the eye changes of Graves' disease. J Clin Endocrinol Metab 1970; 31:307–311.
   PubMed Web of Science ®Google Scholar
• Bigos ST, Nissula BC, Daniels GH, et al: Cyclophosphamide in management of advanced Graves' ophthalmopathy. A preliminary report. Ann Intern Med 1979; 90: 921–923.
   PubMed Web of Science ®Google Scholar
• Wall JR, Strakosch CR, Fang SL, et al: Thyroglobulin-binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: Effect of therapy with cyclophosphamide. Clin Endocrinol 1979; 10:79–91.
   PubMed Web of Science ®Google Scholar
• Kelly W, Longson D, Smithard D, et al: An evaluation of plasma exchange for Graves' ophthalmopathy. Clin Endocrinol 1983; 18: 485–493.
   PubMed Web of Science ®Google Scholar
• Utech C, Wulle KG, Bieler EM, et al: Treatment of severe Graves' ophthalmopathy with cyclosporin A. Acta Endocrinol 1985; 110: 493–498.
   PubMedGoogle Scholar